These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29944521)

  • 21. Economic and technological drivers of generic sterile injectable drug shortages.
    Woodcock J; Wosinska M
    Clin Pharmacol Ther; 2013 Feb; 93(2):170-6. PubMed ID: 23337525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What do pharmaceuticals really cost in the long run?
    Lakdawalla D; MacEwan JP; Dubois R; Westrich K; Berdud M; Towse A
    Am J Manag Care; 2017 Aug; 23(8):488-493. PubMed ID: 29087143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.
    Wouters OJ; Kanavos PG; McKEE M
    Milbank Q; 2017 Sep; 95(3):554-601. PubMed ID: 28895227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of a Pricing Policy Change on Retail Prices of Medicines in Egypt.
    Mohamed O; Kreling DH
    Value Health Reg Issues; 2016 Sep; 10():14-18. PubMed ID: 27881272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial by US Food and Drug Administration Attorney Fails to Address Core and Ongoing Issues Seen With Vasopressin Market.
    Almeter PJ; Hessel EA; Labuhn JA; Morris PE
    Anesth Analg; 2019 Apr; 128(4):e55-e56. PubMed ID: 30730466
    [No Abstract]   [Full Text] [Related]  

  • 27. Review of purchases of unapproved medications by the Veterans Health Administration.
    Carico RL; Emmendorfer TR; Aspinall SL; Mizah MT; Good CB
    Am J Health Syst Pharm; 2019 Nov; 76(23):1934-1943. PubMed ID: 31628792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fixed-dose combination and single active ingredient drugs: a comparative cost analysis.
    Hao J; Rodriguez-Monguio R; Seoane-Vazquez E
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(1):127-34. PubMed ID: 26174631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Contribution Of New Product Entry Versus Existing Product Inflation In The Rising Costs Of Drugs.
    Hernandez I; Good CB; Cutler DM; Gellad WF; Parekh N; Shrank WH
    Health Aff (Millwood); 2019 Jan; 38(1):76-83. PubMed ID: 30615532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in cash price of the generic medications most prescribed by dermatologists in pharmacies across the United States.
    Alghanem N; Abokwidir M; Fleischer AB; Feldman SR; Alghanem W
    J Dermatolog Treat; 2017 Mar; 28(2):119-128. PubMed ID: 27241622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Projecting future drug expenditures--1992.
    Ensor PA
    Am J Hosp Pharm; 1992 Jan; 49(1):140-5. PubMed ID: 1570858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
    Ostroff C; Lee CE; McMeekin J
    Chest; 2011 Aug; 140(2):295-300. PubMed ID: 21813527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of generic substitution on price competition in Finland.
    Aalto-Setälä V
    Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of generic entry in the regulated Taiwanese prescription drug market.
    Liu YM; Cheng JS
    Health Policy; 2012 Dec; 108(2-3):228-35. PubMed ID: 23020970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indian company seeks US approval for generic AIDS drugs.
    Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased topical generic prices by manufacturers.
    Bhatt MD; Bhatt BD; Dorrian JT; McLellan BN
    J Am Acad Dermatol; 2019 May; 80(5):1353-1357. PubMed ID: 29544742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Impact of the expiry of the patent on quality and price of medicines at hospital: Study of five anticancer drugs from 2008 to 2015 at the Assistance publique-Hôpitaux de Paris].
    Siorat V; Raybaut C; Poisson N; Paubel P
    Ann Pharm Fr; 2017 Jan; 75(1):59-66. PubMed ID: 27423185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generic drugs--safe, effective, and affordable.
    Peters JR; Hixon DR; Conner DP; Davit BM; Catterson DM; Parise CM
    Dermatol Ther; 2009; 22(3):229-40. PubMed ID: 19453347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generics: are all immunosuppression agents created equally?
    Hauch A; John M; Smith A; Dortonne I; Patel U; Kandil E; Killackey M; Paramesh A; Lee B; Zhang R; Buell JF
    Surgery; 2015 Oct; 158(4):1049-54; discussion 1054-5. PubMed ID: 26206317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospital reimbursement price cap for cancer drugs: the French experience in controlling hospital drug expenditures.
    Degrassat-Théas A; Bensadon M; Rieu C; Angalakuditi M; Le Pen C; Paubel P
    Pharmacoeconomics; 2012 Jul; 30(7):565-73. PubMed ID: 22686661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.